Sana Biotechnology sells $25M in stock to Mayo Clinic with option for additional $25M

Sana Biotechnology, Inc.

Issued 7,507,507 shares at $3.33 each to Mayo Clinic for ~$25M gross proceeds; closing expected April 15, 2026.
Mayo Clinic can purchase another 7,507,507 shares at same price by Aug 31, 2026, for ~$25M additional.
Net proceeds to fund development of SC451 and genetically modified stem-cell derived islet cell products under new license agreement.
Mayo Clinic subject to 6-month lock-up from initial closing (or 3 months from second closing if elected).
Cash of $138.4M (Dec 31, 2025) plus ~$24.9M net from initial closing expected to fund operations into 2027.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.